Vimarsana
Biggest News Aggregation in the World

Abnormal Coagulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abnormal Coagulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abnormal Coagulation Today - Breaking & Trending Today

Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting - Vimarsana News

Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie's disease, or PD, and XIAFLEX® (collagenase...

Endo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology® - Vimarsana News

Endo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology®

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX® (collagenase clostridium...

Endo International plc: Endo Presents New XIAFLEX (collagenase clostridium histolyticum) Data Analysis at Sexual Medicine Society of North America (SMSNA) Annual Meeting - Vimarsana News

Endo International plc: Endo Presents New XIAFLEX (collagenase clostridium histolyticum) Data Analysis at Sexual Medicine Society of North America (SMSNA) Annual Meeting

DUBLIN, Oct. 22, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that new post-hoc data from two Phase 3 studies of XIAFLEX (collagenase clostridium histolyticum,

Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data Analysis at Sexual Medicine Society of North America (SMSNA) Annual Meeting - Vimarsana News

Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data Analysis at Sexual Medicine Society of North America (SMSNA) Annual Meeting

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that new post-hoc data from two Phase 3 studies of XIAFLEX® (collagenase clostridium...